| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
This Company Proves the “Ten-Bagger Stock” Is No Myth
Back in August 2011, for the very first edition of Private Briefing, I recommended a Belgian biotech firm that I said was “like buying an independent drug development lab” for less than nine bucks a share – $8.60, in fact.
I zeroed in on the company’s collaborative partnerships on a whole slew of drug development programs.
Now, I love to see this in a biotech stock, because it means that some of the usual risks of owning a small, clinical-stage company – running out of money, or the risk of one trial failure wiping out the firm – were minimized.
That arrangement was critical in the massive, almost tenfold gains that followed. (And, as you’ll see, it’s going to be just as important in the bigger gains I see down the road for the folks who bought this company.)
I’ve recommended these shares for my subscribers more than a dozen times since, each time before a fresh bumper crop of profits. This company has given more than 931% in peak gains for Private Briefing subscribers, and a market-crushing 26% since I first shared it with Money Morning Members in September 2016.
There’s a very specific reason I see these gains getting even bigger for everyone in the future…
Tags: Stocks
To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2017 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.
The post This Company Proves the “Ten-Bagger Stock” Is No Myth appeared first on Money Morning – We Make Investing Profitable.
